China Type Testing Medical Devices & IVDs

Type testing, also called in country testing, is a critical step in the regulatory process for medical devices and IVDs seeking approval in China. When conducted in accordance with national standards set by the National Medical Products Administration (NMPA), type testing verifies that products meets performance, safety, and quality requirements before they can be legally marketed.

This process ensures that products are safe for patients and comply with China’s stringent regulatory framework. The final testing report is an essential document reviewed by authorities for product approval.

Chinese testing
Accredited testing institutes
Testing methods

IVD & Medical Device Testing

Medical devices and IVDs must be tested at an NMPA accredited laboratory, where the product samples are tested against the applicable GB and YY standards. These tests check a variety of aspects including, but not limited to, electrical safety (especially for electrical medical equipment), biocompatibility, mechanical performance, and electromagnetic compatibility.

The tests depend on the product’s intended use and classification. The specific test report from these tests forms an integral part of the required documents for the registration application with the NMPA, emphasizing the role of the testing report as a critical document in the registration application. This includes demonstrating conformity to the Product Technical Requirements specific to each product type.

It is also important to include certificates of critical components as part of the necessary documentation for ensuring safety and usability.

Regulatory changes in October 2021 allowed for self-testing under certain conditions, however the process remains complex and is primarily only feasible for large domestic manufacturers with the resources to generate to a self testing report in compliance with NMPA guidelines. For an overseas manufacturer, compliance is easier when working a certified NMPA laboratory, especially given language barriers and the evolving nature of China's testing requirements.

Due to these language issues, complex regulations, and stringent testing measures, many manufacturers hire local regulatory experts such as Cisema, who handle and oversee the type testing process for faster and more accurate results.

How Long Does Type Testing Take?

The duration of type testing in China typically ranges from 4 to 6 months under standard conditions. However, if biocompatibility testing is required, the process may extend to up to 9 months. The high demand for testing services can lead to long waiting times for type testing dates.

Several factors can influence the overall timeline, including:

Device complexity

More complex products may require additional tests, increasing the duration.

Scope of testing

The number and type of tests required, based on applicable GB and YY standards, impact the timeframe.

Laboratory workload

The testing laboratory’s current capacity and schedule can affect processing times.

Documentation & sample submission

Delays in submitting required documents or product samples can prolong the process.

Responsiveness to laboratory questions

From a practical perspective, labs often have testing questions about the specific product.

Biocompatibility tests

These are the only test reports the NMPA accepts from non-NMPA-certified laboratories outside China

Our China Type Testing Services for Medical Devices & IVDs

We provide end-to-end support for Class ii and Class iii medical device and IVD type testing in NMPA-accredited laboratories. Local testing institutes play a crucial role in the evaluation of products, and their involvement is essential to ensure thorough and accurate testing processes. To encounter any difficult testing scenarios, we send our experienced test engineers on-site to supervise all testing in China to guarantee accurate and reliable results.

Our services include:

Pre-Testing Consultation

Assessment of product specifications and regulatory requirements
Identification of applicable testing standards and test items
Guidance on sample preparation and documentation requirements
Evaluation if existing biocompatibility test reports according to ISO-10993 comply with the latest requirements of China NMPA e.g. GB/T 16886
Pre-tests to simulate challenging testing scenarios before the actual type testing
Outlining of product components in the documentation required for compliance during product design and testing processes

Coordination with National Medical Products Administration (NMPA)-Accredited Laboratories

Selection of suitable laboratories based on device category and test scope
Scheduling and coordinating all testing activities
Ensuring proper submission of product samples and technical documents
Understanding the importance of the NMPA as the regulatory body responsible for overseeing the safety, efficacy, and quality of medical devices in China
Addressing the challenges associated with coordinating different testing units that often operate sequentially, leading to potential delays

On-Site Supervision by Test Engineers

Our test engineers are present on-site to oversee the entire testing process. They ensure that all testing details are meticulously addressed during the type testing procedures, facilitating comprehensive evaluations. This includes interactions with reviewers to confirm that all protocols are followed correctly.

Monitoring test procedures to ensure compliance with NMPA protocols
Addressing technical issues and ensuring accurate test execution
Immediate troubleshooting of unexpected testing challenges
Conducting a technical review to ensure compliance with NMPA protocols and address any issues that arise during testing

Test Progress Tracking & Testing Report

Regular updates on testing progress and milestones
Transparent communication of any deviations or additional requirements
Collection and verification of test data and preliminary results

Interpretation of Test Results

Comprehensive review and analysis of test outcomes
Identification of potential non-conformities and recommendations for corrective actions
Clarification of technical terminology and regulatory implications

Documentation & Certification Support

Compilation of final testing reports in compliance with NMPA standards
Assistance with obtaining official test certificates required for product registration
Ensuring proper documentation for future regulatory inspections

Post-Testing Advisory

Guidance on next steps in the NMPA registration process
Recommendations for product modifications if required
Support in addressing test-related inquiries from regulatory authorities

Request a Proposal from Our Life Sciences Team for Type Testing Your Medical Device or IVD in China

Let Cisema help turn your plans into reality.

Request Proposal

Useful Articles

View More

Malaysia Drug–Medical Device Combination Products: A Guide to Classification & Regulatory Pathways

Learn how Malaysia classifies drug–medical device combination products and how the PMOA determines pathways and compliance responsibilities.

April 16, 2026
Malaysia Drug–Medical Device Combination Products: A Guide to Classification & Regulatory Pathways
Laboratory professional in protective eyewear, hair cover, sterile gown, and blue nitrile gloves examining a filled syringe in a clean laboratory environment.

Entering China’s Intraocular Lens (IOL) Market: NMPA Registration Requirements for Foreign Manufacturers

Understand the pathway for intraocular lens (IOL) registration in China, including NMPA requirements and key compliance steps.

April 15, 2026
Entering China’s Intraocular Lens (IOL) Market: NMPA Registration Requirements for Foreign Manufacturers
A close-up of an eye with a transparent intraocular lens held by surgical tweezers positioned in front of the pupil, illustrating ophthalmic medical device use. The visual supports themes of regulatory compliance, product registration, and market access

China Hyaluronic Acid Registration: A Complete Guide

A complete guide to China hyaluronic acid registration, covering classification, NMPA requirements, and compliance steps for manufacturers.

April 16, 2026
China Hyaluronic Acid Registration: A Complete Guide
China Hyaluronic Acid Registration: A Complete Guide

Indonesia's Halal Requirements for Medical Devices: What Manufacturers and Importers Need to Know

Learn which products are covered by Indonesia's halal framework, the labeling and manufacturing obligations, and phased compliance timelines.

April 15, 2026
Indonesia's Halal Requirements for Medical Devices: What Manufacturers and Importers Need to Know
Indonesia's Halal Requirements for Medical Devices: What Manufacturers and Importers Need to Know

Medical Device Registration in Indonesia: A Practical Guide for Foreign Manufacturers

Learn how to register medical devices in Indonesia, including Authorized Representative rules, classification, dossiers, timelines, and fees.

April 15, 2026
Medical Device Registration in Indonesia: A Practical Guide for Foreign Manufacturers
Medical Device Registration in Indonesia: A Practical Guide for Foreign Manufacturers

Medical Devices in China: A Regulatory Glossary for NMPA Compliance

Practical China medical device glossary explaining NMPA terms, with clear comparisons to US FDA and EU MDR terminology.

April 15, 2026
Medical Devices in China: A Regulatory Glossary for NMPA Compliance
Medical Devices in China: A Regulatory Glossary for NMPA Compliance
Previous
Previous

Explore Related Services

Whether you’re just starting out or are a blue-chip, access our wide range of services and solutions to help your business thrive.

China Medical Device Registration

We guide you through every step of Class i filings and Class ii and iii registrations. We take care of compliance with NMPA requirements, advising you on the optimal market entry pathway, and helping you through the whole process.

China NMPA IVD Registration

We support you through every stage of the China IVD registration and filing process, ensuring compliance with NMPA regulations. From choosing the best market entry strategy to handling regulatory requirements, we make the process as smooth as possible.

NMPA Legal Agent

We are your authorized representative in China, and fulfill your registrations and filings as well as ensuring compliance with quality and PMS requirements.

NMPA Clinical Evaluation Report

Clinical Evaluation Reports can avoid the need for a China clinical trial in some instances. Our experts can advise and prepare NMPA compliant CERs.

Drug Device Combination Products

We assist with the classification, registration, and compliance of combination products in China, whether drug or device led.

China Clinical Trials

You may be required to provide supplementary clinical data on Chinese patients or conduct a full clinical trial in China.Our clinical research team will advise you, prepare the study protocol and assist setting up the clinical trial in China.

Medical Device PMS & Vigilance

The NMPA is placing greater focus on Post-Market Surveillance (PMS) such as more in-market sampling inspections and regular standard changes.

Regulatory Outsourcing

If you are seeking specific specialist expertise or have ongoing resource-intensive needs, we have a variety of solutions to meet your needs.

China Medical Device Quality Compliance

We help you achieve and ensure ongoing compliance with Chinese requirements.Our experts prepare and assist you for official NMPA inspections.

How We’ve Helped Clients with Our Expert Guidance

Read about how we work with clients to find solutions, bringing together deep industry knowledge with leading talent.

View More
April 18, 2026

China Manufacture License Renewal for Level A2 Pressure Vessels

How Cisema Supported Inox Torres Group, S.L. in Successfully Renewing its China Manufacture License (SELO) for Level A2 Pressure Vessels

The China Manufacture License (CML), also known as the SELO license, is a mandatory requirement for manufacturers of pressure equipment intended for the Chinese market. Inox Torres Group, S.L.’s manufacturing site produces high-pressure vessels falling under the Level A2 scope. This license ensures compliance with China’s stringent quality and safety regulations for special equipment.

The Challenge: Managing SELO Complexity for High-Risk Equipment

Renewing a SELO license for Level A2 pressure vessels required careful coordination across regulatory, technical, and cultural dimensions.

  • Navigating Regulatory Complexity
    Navigating the complex and evolving SELO regulatory framework, particularly for high-risk products under Level A2, required meticulous planning and real-time compliance updates.
  • Ensuring Audit Readiness
    Inox Torres Group, S.L. needed to ensure all documentation and procedures were fully up to date and to select an appropriate demo product that met inspection requirements.
  • Managing Inspector Expectations
    Success depended on understanding the unspoken cultural and procedural expectations of SELO inspectors, including hosting and on-site hospitality.

Our Solution: Full-Spectrum SELO Audit Support

Recognizing the high stakes of SELO license renewal, Inox Torres Group, S.L. engaged Cisema for comprehensive regulatory and strategic support.

  • Reviewed the Quality Management System
    Cisema led the review and upgrade of the customer’s quality management system in line with the latest Chinese requirements, including a comprehensive gap analysis and revision of key documentation.
  • Audit Simulation & Preparation
    A preparatory remote audit simulation was conducted, walking through every step of the audit to ensure full readiness ahead of the on-site inspection.
  • Delivered On-Site Bilingual & Regulatory Support
    During the on-site audit, Cisema provided continuous bilingual support, interpreting inspector questions in real time and translating regulatory nuances for the customer.
  • Provided Culturally Appropriate Inspector Hosting
    Cisema arranged culturally appropriate corporate hospitality, helping establish a respectful and positive tone for the inspection. The team remained onsite throughout all audit days, including the weekend, to ensure no detail was overlooked.

The Outcome: Successful Renewal Without Disruption

Through hands-on execution and close coordination, the SELO renewal process was completed smoothly and efficiently.

  • Secured CML Renewal with Full A2 Status
    Inox Torres Group, S.L. successfully renewed its China Manufacture License for pressure vessels, maintaining its Level A2 classification.
  • Executed the Project Efficiently
    Full regulatory preparation and audit execution were completed within six months.
  • Achieved Seamless Inspector Coordination
    SELO inspectors were hosted and coordinated smoothly, with culturally aligned engagement throughout the audit.
  • Secured Regulatory Continuity  
    The renewal avoided operational disruptions and ensured compliance with updated SELO requirements.

Expertise and Efficiency: Acting as an Extension of the Client Team

Cisema’s experienced consultants acted as an extension of Inox Torres Group, S.L.’s regulatory and quality teams, providing both regulatory expertise and strategic foresight. Inspector concerns were anticipated and addressed proactively, transforming a potentially stressful process into a streamlined, well-orchestrated engagement with Chinese authorities.

Hands-on mentoring throughout the project helped the customer gain confidence and clarity in managing future SELO audits.

Why Choose Cisema

  • Strategic Regulatory Expertise: Deep understanding of Chinese bureaucracy, evolving SELO requirements, and inspector expectations.
  • Mentorship & Training: Step-by-step guidance that supported the customer’s quality team throughout the process.
  • Corporate Hospitality Excellence: Culturally aligned hosting that supports successful audit outcomes in China.
  • Audit Readiness & Precision: Gap analysis, audit simulation, and documentation refinement to pass SELO reviews efficiently.
  • End-To-End Support: Full management of the audit process, from document revision to on-site interpretation.

Further Information

Explore Cisema’s China Special Equipment (SELO) Certification services.

Learn More
China Manufacture License Renewal for Level A2 Pressure Vessels
Previous
Previous

Latest Insights

View More

Malaysia Introduces New e-IFU & Digital Labelling Guidance for Medical Devices

Malaysia’s MDA publishes the 7th edition of guidance on medical device labelling, with new e-labelling, e-IFU, and accessibility requirements

April 17, 2026
Malaysia Introduces New e-IFU & Digital Labelling Guidance for Medical Devices
Two professionals in an office review documentation for a HealthScreen glucose monitor while examining a computer display showing a product label with model number, barcode, and QR code. One person points to the code on the screen as the other reads.

Vietnam Cuts Advertising Red Tape for Healthcare Products

Vietnam’s MoH recently published Circular drops several healthcare advertising regulations and streamlines requirements for many categories.

April 17, 2026
Vietnam Cuts Advertising Red Tape for Healthcare Products

China NMPA Issues 26 Medical Device Standards Affecting Orthopedics, IVDs, & Software

The 26 new medical device standards cover orthopedic implants, IVDs, active devices, and software risk management.

April 17, 2026
China NMPA Issues 26 Medical Device Standards Affecting Orthopedics, IVDs, & Software

China Mandates Full UDI Compliance for All Medical Devices by 2029

China’s NMPA mandates full UDI coverage for all medical devices by 2029, linking compliance to registration, reimbursement, and market access.

April 17, 2026
China Mandates Full UDI Compliance for All Medical Devices by 2029

China NMPA Clarifies Pre-Review for Innovative Device Clinical Trials

China’s NMPA issues new guidance on clinical trial protocol pre-review for innovative devices, impacting overseas fast-track approvals.

April 17, 2026
China NMPA Clarifies Pre-Review for Innovative Device Clinical Trials

China NMPA Releases 2025 Medical Device Registration Data Report

China NMPA’s 2025 report highlights growth in medical device approvals, including advanced imported devices.

April 17, 2026
China NMPA Releases 2025 Medical Device Registration Data Report
Previous
Previous

Get in Touch with Our Life Sciences Team

And discover how we can support you in undertaking the Type Testing for your medical device or IVD in China.

Request Proposal